IRCT20200522047542N1
Recruiting
Phase 1
Effect of inhaled corticosteroids in the treatment of anosmia in patients with COVID-19
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mashhad University of Medical Sciences
- Enrollment
- 70
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with COVID\-19 who have been referred or admitted to Qaem, Imam Reza, or Shariati Hospital diagnosed with a protocol defined by the World Health Organization.
- •People who have not experienced any signs of reduced sense of smell and taste for at least 2 weeks before the onset of the first manifestation of Covid\-19\.
- •People who were diagnosed with hyposmia or anosmia.
Exclusion Criteria
- •People with certain underlying conditions (such as Parkinson's, Alzheimer's, severe nutritional disorders, acute rhinitis, acute catarrhal sinusitis, SICA syndrome (especially after radiation), nasal mucosal congestion, for example after rhinoplasty, olfactory nerve damage in trauma, etc., which are exposed to the reduction of the sense of smell independent of the coronavirus, as well as, people who experience other viral and bacterial infections simultaneously with COVID\-19
- •People with a history of asthma and allergies are excluded
- •Participants who refused to participate in follow\-up measurements, provide data, or give consent considered withdrawn.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prevention of thunderstorm asthmaThunderstorm asthma.AsthmaIRCT2016102520828N2Ahvaz Jundishapur University of Medical Sciences54
Completed
Phase 3
Does inhaled corticosteroid predispose asthmatic patients to diabetes?Chronic lower respiratory diseases.AsthmaIRCT201605247411N2Ahvaz Jundishapur University of Medical Science28
Withdrawn
Not Applicable
Effectiveness of inhalated corticosteroids in preschool children following hospital admission for acute dyspnea and wheezeEpisodic viral wheezewheeze10038716NL-OMON33152Isala Klinieken62
Completed
Not Applicable
Checking of response to inhaled corticosteroid treatment on a new laboratory parameter (blood CD28) in patients of asthmaHealth Condition 1: J454- Moderate persistent asthmaCTRI/2015/07/005977ady Hardinge Medical College80
Recruiting
Not Applicable
Effect of inhaled corticosteroid therapy in pulmonary sarcoidosis patients who manifest airflow limitatioJPRN-UMIN000013831Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan40